Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease

Authors:

Abstract
Recurrent Clostridium difficile infection (CDI) is of particular concern among healthcare-associated infections. The role of the microbiota in disease recovery is apparent given the success of fecal microbiota transplantation (FMT) for recurrent CDI. Here we present a murine model of CDI relapse to further define the microbiota recovery following FMT. Cefoperazone-treated mice were infected with C. difficile 630 spores and treated with vancomycin after development of clinical disease. Vancomycin treatment suppressed both C. difficile colonization and cytotoxin titers. However, C. difficile counts increased within seven days of completing treatment, accompanied by relapse of clinical signs. The administration of FMT immediately following vancomycin cleared C. difficile and decreased cytotoxicity within one week. The effects of FMT on the gut microbiota community were detectable in recipients 1-day post-transplant. Conversely, mice not treated with FMT remained persistently colonized with high levels of C. difficile and the gut microbiota in these mice persisted at low diversity. These results suggest full recovery of colonization resistance against C. difficile requires the restoration of a specific community structure.

This publication has 33 references indexed in Scilit: